Marshall Islands vs Namibia: Share of children with symptoms of a respiratory infection who received antibiotics
Marshall Islands
50.1%
in 2018
Namibia
49.8%
in 2018
Marshall Islands rank
69th
Namibia rank
71st
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Marshall Islands
- Namibia
How they compare
Marshall Islands currently reports 50.1% against 49.8% in Namibia, a difference of 0.3%.
The two have swapped places 2 times across 19 shared years of data; in 2000 it was Marshall Islands ahead.
Marshall Islands ranks 69th and Namibia ranks 71st of 132 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 37.0% | 13.1% | Marshall Islands |
| 2010s | 49.8% | 45.2% | 4.5% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Marshall Islands or Namibia?
- Marshall Islands, at 50.1% against 49.8% in Namibia as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Marshall Islands and Namibia?
- 0.3%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Namibia?
- 19 years are reported by both, from 2000 to 2018.
- How do Marshall Islands and Namibia rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Marshall Islands ranks 69th and Namibia ranks 71st of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.